Proton-pump inhibitors for the prevention of upper gastrointestinal bleeding in adults receiving antithrombotic therapy

To assess the benefits and harms of PPIs versus histamine-2 receptor antagonists (H2RA) or placebo for the prevention of UGIB in adults receiving antithrombotic therapy for cardiovascular prevention, or prevention and treatment of thromboembolic disease.

This is a protocol.

Share/Save